» Authors » Prabu Rajkumar

Prabu Rajkumar

Explore the profile of Prabu Rajkumar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 117
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Jayaraman Y, Veeraraghavan B, Kumar C, Sukumar B, Rajkumar P, Kangusamy B, et al.
Vaccine . 2021 Jun; 39(28):3737-3744. PMID: 34074545
Introduction: A hospital-based sentinel surveillance network for bacterial meningitis was established in India to estimate the burden of bacterial meningitis, and the proportion of major vaccine-preventable causative organisms. This report...
12.
Mathur P, Kulothungan V, Leburu S, Krishnan A, Chaturvedi H, Salve H, et al.
PLoS One . 2021 Mar; 16(3):e0246712. PMID: 33651825
Background: The primary objective of National NCD monitoring survey (NNMS) was to generate national-level estimates of key NCD indicators identified in the national NCD monitoring framework. This paper describes survey...
13.
Rajkumar P, Bharathy S, Kumar C, Veeraraghavan B, Verghese V, Gupta N, et al.
BMJ Open . 2020 Apr; 10(4):e034663. PMID: 32273315
Introduction: is one of the frequently isolated organisms and an important aetiological agent of invasive bacterial diseases (IBD) like pneumonia, meningitis and sepsis. As a measure to control the burden...
14.
Jayaraman Y, Mehendale S, Jayaraman R, Varghese R, Chethrapilly Purushothaman G, Rajkumar P, et al.
J Infect Public Health . 2018 Apr; 11(5):735-738. PMID: 29606535
Introduction: Streptococcus pneumoniae is a significant cause of childhood bacterial meningitis in India. The United States Food and Drug Administration has licensed an immunochromatographic (ICT) test, BinaxNOW™, to detect the...
15.
16.
Rajkumar P, Pattabi K, Vadivoo S, Bhome A, Brashier B, Bhattacharya P, et al.
BMJ Open . 2017 May; 7(5):e015211. PMID: 28554925
Background: Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable chronic respiratory disease, which affects 210 million people globally. Global and national guidelines exist for the management of...
17.
Manickam P, Mehendale S, Nagaraju B, Katoch K, Jamesh A, Kutaiyan R, et al.
Indian J Med Res . 2017 Mar; 144(4):525-535. PMID: 28256460
Background & Objectives: Uniform therapy for all leprosy patients will simplify leprosy treatment. In this context, we evaluated six-month multidrug therapy (MDT) currently recommended for multibacillary (MB) patients as uniform...